Voltage-gated calcium channel autoimmune cerebellar degeneration

Neurology: Neuroimmunology and NeuroInflammation

Volumn 3, Issue 3, 2016, Pages

  McKasson, Marilyn ^a   Clardy, Stacey L ^a,b   Clawson, Susan A ^b   Hill, Kenneth E ^b   Wood, Blair ^b   Carlson, Noel ^a,b   Bromberg, Mark ^a   Greenlee, John E ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFAMPRIDINE; AUTOANTIBODY; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; PREDNISONE; VOLTAGE GATED CALCIUM CHANNEL;

ACTION POTENTIAL; ADULT; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; ASEPTIC MENINGITIS; AUTOIMMUNE CEREBELLAR DEGENERATION; CASE REPORT; CELL VIABILITY; CEREBELLAR SLICE; CEREBELLUM DEGENERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DETERIORATION; DRUG DOSE INCREASE; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; DYSARTHRIA; EATON LAMBERT SYNDROME; FALLING; GAIT DISORDER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MIDDLE AGED; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PURKINJE CELL; RAT; WEAKNESS;

EID: 85040669495     PISSN: None     EISSN: 23327812     Source Type: Journal    
DOI: 10.1212/NXI.0000000000000222     Document Type: Article

References (15)

1. Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol 2008;7:327-340.
2. Greenlee JE. Treatment of paraneoplastic neurologic disorders. Curr Treat Options Neurol 2010;12:212-230.
3. Blumenfeld AM, Recht LD, Chad DA, DeGirolami U, Griffin T, Jaeckle KA. Coexistence of Lambert-Eaton myasthenic syndrome and subacute cerebellar degeneration: differential effects of treatment. Neurology 1991; 41:1682-1685.
4. Clouston PD, Saper CB, Arbizu T, et al. Paraneoplastic cerebellar degeneration: III: cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome. Neurology 1992;42:1944-1950.
5. Goldstein JM, Waxman SG, Vollmer TL, Lang B, Johnston I, Newsom-Davis J. Subacute cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with antibodies to voltage-gated calcium channels: differential effect of immunosuppressive therapy on central and peripheral defects. J Neurol Neurosurg Psychiatry 1994;57:1138-1139.
6. Mason WP, Graus F, Lang B, et al. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain 1997;120: 1279-1300.
7. Graus F, Lang B, Pozo-Rosich P, Saiz A, Casamitjana R, Vincent A. P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology 2002;59:764-766.
8. Lorenzoni PJ, Scola RH, Lang B, et al. Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome. J Neurol Sci 2008;270:194-196.
9. Iwanami M, Odaka M, Nakamura T, Hirata K. Paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with anti P/Q-type voltage-gated calcium channel antibody in a patient with primary double lung cancer [in Japanese]. Brain Nerve 2009;61:1083-1087.
10. Burk K, Wick M, Roth G, Decker P, Voltz R. Antineuronal antibodies in sporadic late-onset cerebellar ataxia. J Neurol 2010;257:59-62.
11. Rigamonti A, Lauria G, Stanzani L, Mantero V, Andreetta F, Salmaggi A. Non-paraneoplastic voltagegated calcium channels antibody-mediated cerebellar ataxia responsive to IVIG treatment. J Neurol Sci 2014; 336:169-170.
12. Greenlee JE, Clawson SA, Hill KE, Wood BL, Tsunoda I, Carlson NG. Purkinje cell death after uptake of anti-Yoantibodies in cerebellar slice cultures. J Neuropathol Exp Neurol 2010;69:997-1007.
13. Martin-Garcia E, Mannara F, Gutierrez-Cuesta J, et al. Intrathecal injection of P/Q type voltage-gated calcium channel antibodies from paraneoplastic cerebellar degeneration cause ataxia in mice. J Neuroimmunol 2013;261:53-59.
14. Greenlee JE, Clawson SA, Hill KE, et al. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers. PLoS One 2015;10:e0123446.
15. Greenlee JE, Clawson SA, Hill KE, et al. Neuronal uptake of anti-Hu antibody, but not anti-Ri antibody, leads to cell death in brain slice cultures. J Neuroinflammation 2014; 11:160.